A Phase Ii Study Of Bortezomib-Gifox (Gemcitabine, Ifosfamide, Oxaliplatin) In Patients With Newly Diagnosed Natural-Killer/T-Cell Lymphoma
BLOOD(2016)
摘要
Background:
更多查看译文
关键词
lymphoma,oxaliplatin,ifosfamide,bortezomib-gifox,natural-killer,t-cell
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要